Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: Analysis of immunophenotypic marker results of AACTG 5067

被引:42
作者
D'Amico, R
Yang, YJ
Mildvan, D
Evans, SR
Schnizlein-Bick, CT
Hafner, R
Webb, N
Basar, M
Zackin, R
Jacobson, MA
机构
[1] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Indiana Univ, Sch Med, Indianapolis, IN USA
[4] NIH, Div Aids, Bethesda, MD 20892 USA
[5] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA
[6] Univ Calif San Francisco, Dept Med, Posit Hlth Program, San Francisco, CA USA
[7] San Francisco Gen Hosp, Med Serv, San Francisco, CA 94110 USA
关键词
immune reconstitution; CD4; nadir; opportunistic infection; antiretroviral therapy;
D O I
10.1007/s10875-005-2816-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Although initiation of potent antiretroviral therapy (ART) has significantly improved immune perturbations in individuals with AIDS, it is unclear which factors are most important in determining the degree of immune reconstitution. Methods: Whole blood was analyzed at baseline and week 12 in six groups of subjects (n = 81): those with acute or following immune reconstitution after Pneumocystis jirovecii (previously known as Pneumocystis carinii) pneumonia (PcP) (two groups) and cytomegalovirus (CMV) retinitis (two groups), HIV-infection without AIDS (one group), and healthy volunteers (one group). Absolute CD4+ and CD8+ T lymphocytes, naive (CD45RA+) and memory (CD45RO+) CD4+ T lymphocytes and percentages of activated CD8+ T lymphocytes (CD8+/CD38+/HLA-DR), and CD28 expression on CD4+ and CD8+ T lymphocytes were enumerated. Results: The reconstituted CMV group, which had a history of a lower CD4+ T lymphocyte nadir compared to the reconstituted PcP group (15 cells/mm(3) versus 48 cells/mm(3); p = .013), had significantly lower absolute CD4+, CD8+ and naive CD4+ T lymphocytes and a trend toward lower memory CD4+ T lymphocytes compared to the reconstituted PcP group. Moreover, no difference was noted between the reconstituted groups in the proportion of subjects with undetected HIV-1 RNA. The reconstituted subjects had significantly lower absolute CD4+, memory CD4+ and naive CD4+ T lymphocytes than the HIV-positive controls and a significantly higher percentage of activated CD8+ T lymphocytes with a lower percentage of CD8+CD28 expression than the HIV-negative controls. Conclusion: The association of CD4+ T lymphocyte nadir with the extent of immune reconstitution in HIV-infected individuals suggests that HIV-1 may cause irreparable immune system damage despite potent ART.
引用
收藏
页码:106 / 115
页数:10
相关论文
共 40 条
[1]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[2]   EXPRESSION OF COSTIMULATORY MOLECULE CD28 ON T-CELLS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - FUNCTIONAL AND CLINICAL CORRELATIONS [J].
BRINCHMANN, JE ;
DOBLOUG, JH ;
HEGER, BH ;
HAAHEIM, LL ;
SANNES, M ;
EGELAND, T .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :730-738
[3]   Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues [J].
Bucy, RP ;
Hockett, RD ;
Derdeyn, CA ;
Saag, MS ;
Squires, K ;
Sillers, M ;
Mitsuyasu, RT ;
Kilby, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10) :1391-1398
[4]   Declining HIV/AIDS mortality in New York City [J].
Chiasson, MA ;
Berenson, L ;
Li, WH ;
Schwartz, S ;
Singh, T ;
Forlenza, S ;
Mojica, BA ;
Hamburg, MA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (01) :59-64
[5]   CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS [J].
Choremi-Papadopoulou, H ;
Panagiotou, N ;
Samouilidou, E ;
Kontopidou, F ;
Viglis, V ;
Antoniadou, A ;
Kosmidis, J ;
Kordossis, T .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (03) :499-506
[6]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129
[7]  
Gea-Banacloche JC, 1999, AIDS, V13, pS25
[8]   Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation [J].
Hakki, M ;
Riddell, SR ;
Storek, J ;
Carter, RA ;
Stevens-Ayers, T ;
Sudour, P ;
White, K ;
Corey, L ;
Boeckh, M .
BLOOD, 2003, 102 (08) :3060-3067
[9]   REQUIREMENT FOR CD4+ CELLS IN RESISTANCE TO PNEUMOCYSTIS-CARINII PNEUMONIA IN MICE [J].
HARMSEN, AG ;
STANKIEWICZ, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :937-945
[10]   Surrogate markers of immune function in human immunodeficiency virus-infected patients: What are they surrogates for? [J].
Hengel, RL ;
Kovacs, JA .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) :1791-1793